Vega Economics was engaged by a public healthcare technology company to provide a comprehensive analysis of drug spending amongst 304-B hospitals. Vega’s team analyzed drug spending across thousands of hospitals, utilizing both public CMS data as well as subscribed proprietary data, delivering to our client unique insights built on rigorous data analytic and econometric analysis.